MARINA BIOTECH INC COM STK (DE)
MRNA
MRNA was delisted on the 1st of February, 2012.
2 hedge funds and large institutions have $16.2K invested in MARINA BIOTECH INC COM STK (DE) in 2025 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and closing their positions.
979% more capital invested
Capital invested by funds: $1.5K → $16.2K (+$14.7K)
0% more funds holding
Funds holding: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BAM
Byrne Asset Management
Kingston,
New Jersey
|
+$14.5K |
Top Sellers
MRNA Hedge Fund Activity: Q4 2025 in Review
2 of the 8,227 institutional investors tracked by Wall St. Rank reported a position in MARINA BIOTECH INC COM STK (DE) (MRNA) for Q4 2025, worth a combined $16.2K — up 979% from $1.5K a quarter earlier.
Fund positioning in MRNA was balanced in Q4 2025: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Byrne Asset Management, adding an estimated $14.5K.
- 2 institutional investors held MARINA BIOTECH INC COM STK (DE) (MRNA) as of Q4 2025, unchanged from Q3 2025.
- Funds reported $16.2K of MARINA BIOTECH INC COM STK (DE) stock for Q4 2025, up 979% quarter-over-quarter.
- 0 funds opened new MARINA BIOTECH INC COM STK (DE) positions in Q4 2025 and 0 closed out.
- The largest MARINA BIOTECH INC COM STK (DE) buyer in Q4 2025 was Byrne Asset Management, an estimated $14.5K added.
Based on aggregated 13F filings for Q4 2025.